-
Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review
10 Apr 2024 07:09 GMT
… primary and metastatic breast cancers, respectively.81,82 … -positive metastatic breast cancer. Clin Breast Cancer. 2021;21 … exemestane treatment in metastatic hormone receptor-positive breast cancer … receptor-positive breast cancer. NPJ Breast Cancer. 2018;4 …
-
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
20 Mar 2024 19:10 GMT
… of either anastrozole, exemestane, letrozole, fulvestrant or … receptor-positive metastatic breast cancer.
“Although there … receptor-positive metastatic breast cancer and in biomarker … overexpressed/amplified breast cancer, following adjuvant trastuzumab …
-
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
20 Mar 2024 13:07 GMT
… of either anastrozole, exemestane, letrozole, fulvestrant or … receptor-positive metastatic breast cancer.
“Although there … receptor-positive metastatic breast cancer and in biomarker … overexpressed/amplified breast cancer, following adjuvant trastuzumab …
-
Puma Biotechnology unveils Phase II breast cancer trial design
12 Dec 2023 12:58 GMT
… , hormone receptor-positive metastatic breast cancer.
Following talks with the … naïve breast cancer patients.
The endocrine treatment comprises either anastrozole, exemestane, … hormone receptor-positive metastatic breast cancer have demonstrated alisertib’s …
-
Puma Biotechnology Announces Phase II Clinical Trial Design for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
11 Dec 2023 13:44 GMT
… of either anastrozole, exemestane, letrozole, fulvestrant or … receptor-positive metastatic breast cancer. Patients must have … receptor-positive metastatic breast cancer have demonstrated alisertib’ … overexpressed/amplified breast cancer, following adjuvant …
-
Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer (mBC) with ESR1 Mutations at SABCS 2023
08 Dec 2023 14:05 GMT
… advanced or metastatic breast cancer with disease progression … fulvestrant, letrozole, anastrozole, exemestane), across these subgroups. … advanced or metastatic breast cancer with disease progression … or metastatic breast cancer with disease progression …
-
Breast cancer prevention drug approved for post-menopausal women in the UK – here's how it works
08 Nov 2023 17:49 GMT
… reduces oestrogen levels, preventing breast cancer cells from dividing. It … – such as letrozole and exemestane – stop aromatase from working … .
The majority of breast cancers produce a protein which … also works to prevent breast cancer is because often …
-
Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative Study
06 Nov 2023 08:34 GMT
… cancers, including breast cancer.5 About 70–80% of breast cancers are hormone receptor … (AIs) (eg, anastrozole, letrozole and exemestane). OET is prescribed to prevent … in women with breast cancer: the role of comorbidity. Breast Cancer Res Treat. 2018 …
-
Breast Cancer: An Overview of Current Therapeutic Strategies, Challenge, and Perspectives
20 Oct 2023 07:24 GMT
… care for most breast cancers. However, the … in operable breast cancer, convert inoperable breast cancer to resectable … in breast cancer, such as gene therapy, breast cancer vaccines … Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. …
-
October is National Breast Cancer Awareness Month, so now is the perfect time to support the 2024 Australian Women’s Health Diary
02 Oct 2023 22:00 GMT
… Diary.
All proceeds support breast cancer trials research that is identifying … Herceptin, Exemestane, Letrozole and Tamoxifen identified through the Breast Cancer Trials research … – Fundraising and Philanthropy at Breast Cancer Trials, has said that more …